Q-Bank Breakdown: Hypokalemia & hyperkalemia — Why Every Answer Choice Matters

Electrolyte questions are the ultimate “every answer choice matters” traps—especially potassium. On Step 1/2, you’re rarely just asked “what’s the potassium?” You’re asked to identify the mechanism (shift vs true loss), anticipate ECG changes, connect acid–base physiology, and pick the single management step that prevents a bad outcome. Let’s break down a classic Q-bank-style vignette and then dissect each distractor like you would on test day.

---

Tag: Renal > Fluid, Electrolytes & Acid-Base

The Clinical Vignette (Q-bank style)

A 58-year-old man with type 2 diabetes and hypertension comes to the ED for weakness and palpitations. He missed dialysis this week due to travel. Medications include lisinopril. Vitals: BP 148/86, HR 112. Exam shows mild muscle weakness. ECG shows tall, narrow, peaked T waves. Labs:

• Na⁺ 138 mEq/L
• K⁺ 6.9 mEq/L
• Cl⁻ 102 mEq/L
• HCO₃⁻ 18 mEq/L
• BUN/Cr elevated (known ESRD)

Question: What is the most appropriate immediate next step?

Correct Answer: IV calcium gluconate

Why it’s correct

This patient has severe hyperkalemia with ECG changes. The immediate threat is ventricular arrhythmia due to potassium’s effect on cardiac membrane excitability. IV calcium gluconate stabilizes the cardiac myocyte membrane quickly (minutes), reducing risk of lethal dysrhythmias.

Key point:

• Calcium does not lower serum potassium.
• It buys time while you shift K⁺ into cells and remove it from the body.

---

The High-Yield Framework: Hyperkalemia Management (in order)

Think of three goals—stabilize, shift, shred (remove).

ESRD clue: If they missed dialysis and are oliguric/anuric, dialysis is definitive—but calcium comes first when ECG changes are present.

---

Now the Money Part: Why Each Distractor Is Wrong (or incomplete)

Below are common answer choices on USMLE-style items—your job is to eliminate them for the right reason.

Distractor 1: Insulin with dextrose

Why it’s tempting: It’s a cornerstone therapy and lowers potassium quickly.
Why it’s not the best immediate step here: ECG changes = unstable electrical substrate. You stabilize the myocardium first with calcium.

• Insulin moves K⁺ into cells by stimulating Na⁺/K⁺-ATPase.
• Dextrose prevents hypoglycemia (unless glucose already very high—some vignettes will let you skip dextrose).

Test-day rule:

• HyperK + ECG changes → Calcium first, then insulin/glucose.

---

Distractor 2: Albuterol (β₂-agonist)

Why it’s tempting: Also shifts K⁺ intracellularly.
Why it’s not the best immediate step: Same issue—doesn’t stabilize the myocardium. Also, response can be variable and less predictable than insulin.

Extra high yield: β₂-agonists stimulate Na⁺/K⁺-ATPase → intracellular K⁺ shift.
(And yes, this is why albuterol can cause hypokalemia.)

---

Distractor 3: Sodium bicarbonate

Why it’s tempting: The patient is acidotic (HCO₃⁻ 18), and acidosis is associated with hyperkalemia.
Why it’s usually not the first move: Bicarbonate is not reliably effective for acute hyperkalemia unless there’s significant metabolic acidosis and even then is adjunctive—not definitive and not myocardium-stabilizing.

High-yield physiology (Step 1 favorite):

• In metabolic acidosis, H⁺ moves into cells → K⁺ tends to move out to maintain electroneutrality → hyperkalemia.
• Exception you’ll see tested: organic acidosis (e.g., lactic acidosis, ketoacidosis) causes less K⁺ shift than mineral acidosis because the organic anions often enter cells with H⁺.

---

Distractor 4: Furosemide (loop diuretic)

Why it’s tempting: Loops increase urinary K⁺ excretion.
Why it’s wrong here: ESRD patient who missed dialysis likely has minimal urine output, so loop diuretics won’t remove enough K⁺ quickly (or at all).

When loops are reasonable: Hyperkalemia in a patient who is making urine, volume overloaded, or needs enhanced renal potassium excretion.

---

Distractor 5: Sodium polystyrene sulfonate (kayexalate) / potassium binders

Why it’s tempting: “Removes potassium from the body” sounds definitive.
Why it’s wrong as the immediate step: Onset is too slow for ECG-changes hyperkalemia. Also, older binders have safety/efficacy caveats.

• Kayexalate has been associated with intestinal necrosis (especially with sorbitol; classic caution).
• Newer binders (patiromer, sodium zirconium cyclosilicate) are more often used in chronic management—still not your acute “save the heart now” answer.

---

Distractor 6: Stop the ACE inhibitor (lisinopril)

Why it’s tempting: ACE inhibitors reduce aldosterone → can cause hyperkalemia.
Why it’s incomplete: Stopping the cause doesn’t treat the current life-threatening hyperkalemia with ECG changes.

High-yield mechanism:

• ↓ Angiotensin II → ↓ aldosterone → ↓ ENaC activity in principal cells → ↓ K⁺ secretion.

---

Distractor 7: Normal saline infusion

Why it’s tempting: Fluids are often “safe.”
Why it’s wrong: This is not primarily a volume depletion problem, and fluids won’t acutely fix dangerous hyperkalemia in ESRD (and may worsen volume overload).

---

ECG Progression You Must Know (HyperK vs HypoK)

Hyperkalemia ECG (in order—classic progression)

• Peaked T waves
• Prolonged PR
• Widened QRS
• Loss of P waves
• Sine wave → VF/asystole

Hypokalemia ECG

• Flattened T waves
• U waves
• ST depression, prolonged QT (often functionally “longer repolarization”)
• Increased risk of arrhythmias (esp. with digoxin)

USMLE pearl: If the vignette gives ECG changes, you’re supposed to treat the rhythm risk—not just “fix the number.”

---

Rapid-Fire High-Yield: Hypokalemia vs Hyperkalemia Differentials

Step 1/2 must-sort question: “Is it a shift or a true deficit/excess?”

Hypokalemia causes

Shift into cells (serum low, total body K normal):

• Insulin
• β₂-agonists (albuterol)
• Alkalosis

True loss (total body K low):

• GI loss: diarrhea (often metabolic acidosis), vomiting (metabolic alkalosis)
• Renal loss: diuretics (loop/thiazide), hyperaldosteronism, renal tubular disorders
• Hypomagnesemia (impairs K repletion)

Hyperkalemia causes

Shift out of cells (total body K may be normal):

• Acidosis (esp mineral)
• Insulin deficiency (DKA has hyperkalemia despite total-body K depletion)
• Cell lysis: rhabdomyolysis, tumor lysis, hemolysis
• β-blockers (less cellular uptake)

True excess or impaired excretion:

• Renal failure
• Hypoaldosteronism (Type 4 RTA)
• Drugs: ACEi/ARB, spironolactone/eplerenone, amiloride/triamterene, TMP-SMX (acts like amiloride), NSAIDs (↓ renin)

---

Mini-Bridge to Acid–Base (USMLE loves this connection)

Type 4 RTA = Hyperkalemic metabolic acidosis

• Mechanism: hypoaldosteronism or aldosterone resistance → decreased H⁺ secretion (α-intercalated) and decreased K⁺ secretion (principal cells)
• Common in diabetics (hyporeninemic hypoaldosteronism)
• Labs: normal anion gap metabolic acidosis + hyperkalemia

Memory anchor: Type 4 is the only RTA with high K.

---

How This Looks on Test Day: “What are they really asking?”

If the stem gives…

• K ≥ 6.5 OR ECG changes → IV calcium (stabilize)
• No ECG changes but high K → shift (insulin/glucose, albuterol) + remove cause/elimination
• ESRD + missed dialysis → strong lean toward dialysis as definitive removal (after calcium if ECG changes)
• DKA → potassium may be high but total-body K is low → once insulin starts, K will drop

---

Take-Home Cheat Sheet (what to remember under pressure)

• Calcium gluconate = membrane stabilization (fastest life-saving step with ECG changes).
• Insulin + dextrose = fastest reliable shift (but doesn’t stabilize).
• Dialysis = definitive in ESRD (but don’t skip calcium when ECG is abnormal).
• Hypokalemia + can’t replete = check magnesium.
• Type 4 RTA = hyperK + NAGMA, often in diabetics.